Other Viruses Citation List:
April 1 - April 14, 2011
Herpes simplex virus
1. Effect of Caffeine on the Multiplication of DNA and RNA Viruses. Murayama, M., K. Tsujimoto, M. Uozaki, Y. Katsuyama, H. Yamasaki, H. Utsunomiya, and A.H. Koyama. Molecular Medicine Reports, 2008. 1(2): p. 251-255; PMID[21479405].
[Pubmed]. OV_0401-041411.
2. Generation of Neutralising Aptamers against HSV-2: Potential Components of Multivalent Microbicides. Moore, M.D., D.H. Bunka, M. Forzan, P. Spear, P.G. Stockley, I. McGowan, and W.S. James. The Journal of General Virology, 2011. [Epub ahead of print]; PMID[21471320].
[Pubmed]. OV_0401-041411.
Hepatitis B virus
3. Two New Lignans and Anti-HBV Constituents from Illicium Henryi. Liu, J.F., Z.Y. Jiang, C.A. Geng, Q. Zhang, Y. Shi, Y.B. Ma, X.M. Zhang, and J.J. Chen. Chemistry & Biodiversity, 2011. 8(4): p. 692-698; PMID[21480515].
[Pubmed]. OV_0401-041411.
4. Epigallocatechin Gallate Inhibits HBV DNA Synthesis in a Viral Replication - Inducible Cell Line. He, W., L.X. Li, Q.J. Liao, C.L. Liu, and X.L. Chen. World Journal of Gastroenterology : WJG, 2011. 17(11): p. 1507-1514; PMID[21472112].
[Pubmed]. OV_0401-041411.
Hepatitis C virus
5. Antiviral Activity of the Hepatitis C Virus Polymerase Inhibitor Filibuvir in Genotype 1 Infected Patients. Wagner, F., R. Thompson, C. Kantaridis, P. Simpson, P.J. Troke, S. Jagannatha, S. Neelakantan, V.S. Purohit, and J.L. Hammond. Hepatology (Baltimore, Md.), 2011. [Epub ahead of print]; PMID[21488067].
[Pubmed]. OV_0401-041411.
6. Syntheses and Initial Evaluation of a Series of Indolo-Fused Heterocyclic Inhibitors of the Polymerase Enzyme (Ns5b) of the Hepatitis C Virus. Zheng, X., T.W. Hudyma, S.W. Martin, C. Bergstrom, M. Ding, F. He, J. Romine, M.A. Poss, J.F. Kadow, C.H. Chang, J. Wan, M.R. Witmer, P. Morin, D.M. Camac, S. Sheriff, B.R. Beno, K.L. Rigat, Y.K. Wang, R. Fridell, J. Lemm, D. Qiu, M. Liu, S. Voss, L. Pelosi, S.B. Roberts, M. Gao, J. Knipe, and R.G. Gentles. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21486696].
[Pubmed]. OV_0401-041411.
7. Colony-Forming Assays Reveal Enhanced Suppression of Hepatitis C Virus Replication Using Combinations of Direct-Acting Antivirals. Graham, E.J., R. Hunt, S.M. Shaw, C. Pickford, J. Hammond, M. Westby, and P. Targett-Adams. Journal of Virological Methods, 2011. [Epub ahead of print]; PMID[21473883].
[Pubmed]. OV_0401-041411.
8. Fused Heterocyclic Amido Compounds as Anti-Hepatitis C Virus Agents. Aoyama, H., K. Sugita, M. Nakamura, A. Aoyama, M.T. Salim, M. Okamoto, M. Baba, and Y. Hashimoto. Bioorganic & Medicinal Chemistry, 2011. 19(8): p. 2675-2687; PMID[21458278].
[Pubmed]. OV_0401-041411.
9. Inhibition of HCV 3a Core Gene through Silymarin and Its Fractions. Ashfaq, U.A., T. Javed, S. Rehman, Z. Nawaz, and S. Riazuddin. Virology Journal, 2011. 8(1): p. 153; PMID[21453551].
[Pubmed]. OV_0401-041411.
10. SAR Studies on a Series of N-Benzyl-4-Heteroaryl-1-(Phenylsulfonyl)Piperazine-2-Carboxamides: Potent Inhibitors of the Polymerase Enzyme (Ns5b) of the Hepatitis C Virus. Gentles, R.G., M. Ding, X. Zheng, L. Chupak, M.A. Poss, B.R. Beno, L. Pelosi, M. Liu, J. Lemm, Y.K. Wang, S. Roberts, M. Gao, and J. Kadow. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21450465].
[Pubmed]. OV_0401-041411.
Citations from the ISI Web of Knowledge Listings for O.I.
11. Synthesis and SAR of Acyclic HCV Ns3 Protease Inhibitors with Novel P4-Benzoxaborole Moieties. Li, X.F., S.M. Zhang, Y.K. Zhang, Y. Liu, C.Z. Ding, Y. Zhou, J.J. Plattner, S.J. Baker, W. Bu, L.A. Liu, W.M. Kazmierski, M.S. Duan, R.M. Grimes, L.L. Wright, G.K. Smith, R.L. Jarvest, J.J. Ji, J.P. Cooper, M.D. Tallant, R.M. Crosby, K. Creech, Z.J. Ni, W.X. Zou, and J. Wright. Bioorganic & Medicinal Chemistry Letters, 2011. 21(7): p. 2048-2054; ISI[000288245100031].
[WOS]. OV_0401-041411.
12. Inhibitors of HCV Ns5a: From Iminothiazolidinones to Symmetrical Stilbenes. Romine, J.L., D.R. St Laurent, J.E. Leet, S.W. Martin, M.H. Serrano-Wu, F.K. Yang, M. Gao, D.R. O'Boyle, J.A. Lemm, J.H. Sun, P.T. Nower, X.H. Huang, M.S. Deshpande, N.A. Meanwell, and L.B. Snyder. ACS Medicinal Chemistry Letters, 2011. 2(3): p. 224-229; ISI[000288401500007].
[WOS]. OV_0401-041411.
13. Discovery of Mk-1220: A Macrocyclic Inhibitor of Hepatitis C Virus Ns3/4a Protease with Improved Preclinical Plasma Exposure. Rudd, M.T., J.A. McCauley, J.W. Butcher, J.J. Romano, C.J. McIntyre, K.T. Nguyen, K.F. Gilbert, K.J. Bush, M.K. Holloway, J. Swestock, B.L. Wan, S.S. Carroll, J.M. DiMuzio, D.J. Graham, S.W. Ludmerer, M.W. Stahlhut, C.M. Fandozzi, N. Trainor, D.B. Olsen, J.P. Vacca, and N.J. Liverton. ACS Medicinal Chemistry Letters, 2011. 2(3): p. 207-212; ISI[000288401500004]. [WOS]. OV_0401-041411.
14. QSAR Based Modeling of Hepatitis C Virus Ns5b Inhibitors. Srivastava, A.K., A. Pandey, A. Srivastava, and N. Shukla. Journal of Saudi Chemical Society, 2011. 15(1): p. 25-28; ISI[000288844500004]. [WOS]. OV_0401-041411.